Nexo
Founded 2022 · 19 employees on LinkedIn · 1 known investors
Nexo Therapeutics develops drugs aimed at "undruggable" disease targets, such as intrinsically disordered proteins, scaffolding proteins, transcription factors, and protein-protein interfaces. It applies chemical biology and pharmacology through covalent ligand discovery across nucleophilic amino acids.
Investors · 1
Frequently asked questions
- What does Nexo do?
- Nexo Therapeutics develops drugs aimed at "undruggable" disease targets, such as intrinsically disordered proteins, scaffolding proteins, transcription factors, and protein-protein interfaces. It applies chemical biology and pharmacology through covalent ligand discovery across nucleophilic amino acids.
- Who are Nexo's investors?
- Nexo's investors include New Enterprise Associates (NEA).